Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
HX 531 is a novel RXR antagonist used to enhance transactivation of PPARγ and ST 13 preadipocyte differentiation. Helps in the reduction of triglyceride content in white adipose tissue, skeletal muscle and liver.